DROPERIDOL | A070993 | ABRAXIS PHARMACEUTICAL PRODUCTS
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Providence St. Peter Hospital / Centralia Hospital FDA-2022-P-2238 · 6 docket documents Providence St. Peter Hospital, represented by pharmacists including Julie McCoy, filed this citizen petition under 21 C.F.R. § 10.25(a) requesting that the FDA amend the boxed warning for droperidol by removing five sentences that address prescribing restrictions, QT prolongation risk statements, an | Other | 2022-09-14 | Withdrawn | Providence St. Peter Hospital / Centralia Hospital |
Citizen Petition from Providence St. Peter Hospital/Centralia Hospital FDA-2022-P-1409 · 43 docket documents Providence St. Peter Hospital and Centralia Hospital, represented by Julie McCoy and other pharmacists, filed this citizen petition under 21 C.F.R. § 10.25(a) requesting that the FDA amend the boxed warning for droperidol by removing five sentences that the petitioners argue are redundant, overly pr | Other | 2022-07-01 | Denied | Providence St. Peter Hospital/Centralia Hospital |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.